Andrew Chang

Andrew Chang

Company: Novo Nordisk

Job title: VP Quality & Regulatory Compliance


Continuous Manufacturing for Biologics: Opportunities & Challenges 11:30 am

• What are the central questions and business opportunities for introducing continuous manufacturing (CM) for biologics? • What are the opportunities and challenges ahead for wider spread adoption and application of CM for biologics • A case study: Post-approval change of upstream manufacturing process to CMRead more

day: Stream 2 - Day 1 AM

Panel Discussion: Where Does the Implementation of CM Bring the Most Value? 9:45 am

• Legacy vs Pipeline Products: Contrasting a potentially quicker time to market with saved manufacturing costs, what brings the most value? • What are the switch points to move into continuous at R&D, Early Phase or Late Phase? • Which modalities stand to benefit the most from this technology? • As drug move off patent…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.